PCR (Polymerase Chain Reaction) primer group for detecting porcine reproductive and respiratory syndrome virus and nanopore sequencing method based on single molecule sequencing

By designing PCR primer sets and single-molecule sequencing methods, the problem of detecting multiple genotypes of porcine reproductive and respiratory syndrome virus was solved, enabling rapid and accurate identification of viral genotypes and supporting epidemic management in the livestock industry.

CN118910333AInactive Publication Date: 2024-11-08ZHEJIANG FORESTRY UNIVERSITY +3
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
CN202411333368.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-24
Publication Date
2024-11-08
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

Current technologies make it difficult to quickly and accurately detect multiple genotypes of porcine reproductive and respiratory syndrome virus, leading to difficulties in epidemic prevention and control.

Method used

A PCR primer set and a nanopore sequencing method based on single-molecule sequencing were designed, including 12 pairs of primers and their probes. Through 12-fold quantitative real-time PCR amplification, sequencing library construction and bioinformatics analysis, the genotyping of six porcine reproductive and respiratory syndrome viruses can be detected simultaneously.

Benefits of technology

It enables rapid and accurate identification of six genotypes of porcine reproductive and respiratory syndrome virus, supporting routine monitoring and emergency control in large-scale farming, and has high sensitivity and high specificity.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118910333A_ABST
    Figure CN118910333A_ABST
Patent Text Reader

Abstract

The invention discloses a PCR (Polymerase Chain Reaction) primer group for detecting porcine reproductive and respiratory syndrome virus and a nanopore sequencing method based on single molecule sequencing. The multiplex PCR amplification specific primer group can realize rapid identification of six genotypes of the porcine reproductive and respiratory syndrome (PRRSV): a PRRSV European strain, a PRRSV American classical strain (C-PRRSV) representing a pedigree 5, a highly viral strain (HP-PRRSV) representing a pedigree 8, an NADC30 strain (NADC30) and an NADC34 strain (NADC34) representing a pedigree 1, and a PRRSV GM2 representing a pedigree 3. The porcine reproductive and respiratory syndrome genotype in each sample can be simultaneously detected in one reaction hole, and the method has great significance on normal porcine reproductive and respiratory syndrome detection in large-scale culture and emergency prevention and control when a porcine reproductive and respiratory syndrome epidemic situation occurs.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of biotechnology, and in particular relates to a PCR primer set for detecting porcine reproductive and respiratory syndrome virus and a nanopore sequencing method based on single-molecule sequencing. Background Art

[0002] PRRS (Porcine Reproductive and Respiratory Syndrome, also known as blue ear disease) is an important infectious disease caused by the Porcine Reproductive and Respiratory Syndrome Virus (PRRSV), which causes reproductive disorders in pregnant sows and respiratory symptoms in pigs of all ages. After the disease occurs in pregnant sows, the litter rate decreases, and the rates of miscarriage, stillbirth and weak fetuses can reach 30% to 100%; after the disease occurs in fattening pigs, they show symptoms such as difficulty breathing, multiple secondary infections, slow production and reduced feed returns.

[0003] PRRSV is a single-stranded positive-sense RNA virus, which is divided into European (genotype I) strains and American (genotype II) strains. PRRSV has a super strong mutation ability, forming a complex situation of circulation of multiple mutant strains. Highly pathogenic PRRSV (HP-PRRSV) is characterized by a discontinuous deletion of 30 amino acids in the viral Nsp2 protein, and it is still one of the main epidemic strains. In 2012, a NADC30-like strain (NADC30-Like PRRSV) highly homologous to the NADC30 strain was discovered, characterized by a discontinuous deletion of 131 amino acids in Nsp2. In 2017, NADC34-like PRRSV (NADC34-Like PRRSV) was discovered, whose Nsp2 protein had a continuous deletion of 100 amino acids. It is relatively less pathogenic to piglets and is a potential epidemic strain.

[0004] It has been more than 30 years since PRRS was discovered. Researchers have made some important research progress in the isolation and identification of the pathogen, viral genetic variation, viral protein structure and function, immunity and pathogenic mechanism, vaccine and diagnostic preparation creation, and prevention and control technology, which has promoted the understanding of the disease.

[0005] Despite this, due to the continuous emergence of mutant or recombinant strains and the lack of systematic and in-depth research on PRRS immunity and pathogenicity, PRRS is still an important infectious disease that endangers the global pig industry and is also a key prevention and control target for pig farms. Therefore, the genetic typing test of blue ear disease is of great significance for its prevention and control. Summary of the invention

[0006] The purpose of this section is to summarize some aspects of embodiments of the present invention and to briefly introduce some preferred embodiments.

[0007] As one aspect of the present invention, the present invention provides a PCR primer set for detecting porcine reproductive and respiratory syndrome virus, wherein: the PCR primer set consists of 12 pairs of primers and probes thereof, and the sequences of the PCR primers are shown in SEQ ID NOs: 1-36.

[0008] The present invention also provides the nanopore sequencing method based on single-molecule sequencing: comprising using the PCR primer set described in claim 1 to detect six types of porcine reproductive and respiratory syndrome virus, including PRRSV-1 (European type, represented by Lelystadvirus, i.e., LV strain), C-PRRSV in the American type (classical strain, represented by VR-2332 strain), HP-PRRSV (highly pathogenic PRRSV strain, represented by JXA1 strain), NADC30 strain, NADC34 strain, and GM2 strain.

[0009] As a preferred embodiment of the nanopore sequencing method for single molecule sequencing of the present invention, it comprises the following steps:

[0010] (1) Sample collection and viral nucleic acid extraction;

[0011] (2) 12-plex fluorescence quantitative PCR amplification;

[0012] (3) Construction of sequencing library;

[0013] (4) PRRSV multi-genotype sequencing;

[0014] (5) Bioinformatics analysis;

[0015] Wherein, the 12-plex fluorescence quantitative PCR amplification adopts the 12 pairs of primers and probes thereof as described in claim 1 for PCR amplification.

[0016] As a preferred solution of the nanopore sequencing method for single-molecule sequencing described in the present invention: the amplification program of the 12-plex fluorescent quantitative PCR is: pre-denaturation at 95°C for 3 min, denaturation at 95°C for 10 s, extension at 65°C for 3 min, and 40 reaction cycles.

[0017] As a preferred embodiment of the nanopore sequencing method for single-molecule sequencing described in the present invention: the sample includes a saliva sample, an environmental sample, a blood sample, and a tissue sample.

[0018] As a preferred embodiment of the nanopore sequencing method for single-molecule sequencing of the present invention: the construction of the sequencing library is to construct the nanopore sequencing library according to the ligation kit, including PCR product purification, end repair, label ligation, and adapter ligation.

[0019] As a preferred solution of the nanopore sequencing method for single-molecule sequencing described in the present invention: the bioinformatics analysis includes database establishment, data capture, host sequence removal, data analysis, detection pathogen proportion statistics, and database comparison.

[0020] Beneficial effects of the present invention: The multiplex PCR amplification specific primer set of the present invention can realize the rapid identification of six genotypes of blue ear: PRRSV-1 European strain, PRRSV American classical strain (C-PRRSV) representing lineage 5, highly pathogenic strain (HP-PRRSV) representing lineage 8, NADC30 strain (NADC30) and NADC34 strain (NADC34) representing lineage 1, GM2 strain representing lineage 3. Two pairs of primers are designed for each genotype. The present invention can simultaneously detect the blue ear genotype in each sample in one reaction well. The method of the present invention is of great significance for normal blue ear detection in large-scale breeding and emergency prevention and control when a blue ear epidemic occurs. BRIEF DESCRIPTION OF THE DRAWINGS

[0021] In order to more clearly illustrate the technical solutions of the embodiments of the present invention, the accompanying drawings required for use in the description of the embodiments will be briefly introduced below. Obviously, the accompanying drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other accompanying drawings can be obtained based on these accompanying drawings without paying creative labor.

[0022] in:

[0023] Figure 1 Flow chart of the nanopore sequencing method. DETAILED DESCRIPTION

[0024] In order to make the above-mentioned objects, features and advantages of the present invention more obvious and easy to understand, the specific implementation methods of the present invention are described in detail below in conjunction with specific embodiments.

[0025] Embodiment 1:

[0026] The primer and probe designs for the six types of PRRSV are shown in Table 1:

[0027] Table 1

[0028]

[0029]

[0030]

[0031] In the table, PRRSV-NADC30-F-1 represents the first pair of upstream primer sequences, PRRSV-NADC30-R-1 represents the first pair of downstream primer sequences, PRRSV-NADC30-P-1 represents the first pair of primer probes, and so on, for a total of 12 pairs of primers.

[0032] Optimization of twelve-plex fluorescence quantitative PCR and establishment of standard curve:

[0033] Primer probe dilution and sample processing:

[0034] The 12 sets of primer probes were diluted to 100umol / L with TE Buffer as recommended. Applicable sample types include nasopharyngeal swabs, environmental samples, serum, blood swabs, tissue samples, and stool samples.

[0035] Single-plex fluorescence quantitative PCR verification: First, the single-plex primers and probes were independently verified, and the verification results showed good specificity and repeatability. In the second step, the 12 pairs of primers and probes were mixed and amplified without adding amplification template. The results showed negative, indicating that there was no dimer between the 12 pairs of primers and no primer complementarity.

[0036] Optimization of twelve-plex fluorescence quantitative PCR: Use the gradient method to gradually optimize the concentration of primers and probes: dilute the primers and probes to different concentrations in a gradient. Change the concentration of a single pair of primers and a single probe, set up multiple groups, test the same positive plasmid on the machine at the same time, and select a set of solutions with the same fluorescence intensity and similar Ct value as the single-plex fluorescence quantitative PCR as the optimal solution.

[0037] The multiplex PCR reaction enzyme was biotechrabbit multiplex fluorescence quantitative PCR enzyme, the brand of the fluorescence quantitative PCR instrument was Tianlong Technology 96R, and the concentrations of primers and probes after optimization were: primers 500nmol / L, probes 50nmol / L; after optimization, the determined reaction system was 20uL: 4×CAPITAL qPCR Probe Master Mi×5uL, 20×RTase with RNase Inhibitor1uL, total primer volume 6uL, total probe volume 3uL, sample nucleic acid 5uL; the reaction procedure was as follows: reverse transcription 50℃10min, pre-denaturation 95℃3min, denaturation 95℃10s, extension 65℃3min, reaction cycle number 40, and all probes were FAM channels.

[0038] Establishment of twelve-plex fluorescence quantitative PCR standard curve: Determine the concentration of the synthesized plasmid and calculate the copy number according to the following formula: double-stranded DNA copy number (copies / mL) = 6.02 × 10 23(copies / mL)×concentration (g / mL) / recombinant plasmid length×660; dilute the positive plasmid to 3×10 8 copies / mL, and then diluted 10-fold to select 7 concentrations (10 8 copies / mL~10 2 The mixture of 1000 copies / mL recombinant plasmid standards was used as a template, and multiple fluorescence quantitative PCR amplification was performed according to the optimized reaction system and conditions. A standard curve was established with the logarithm of the standard concentration as the abscissa and the Ct value as the ordinate.

[0039] Twelve-fold fluorescence quantitative PCR sensitivity test: The dilution method of 12 blue ear virus positive plasmids is as follows: In the clean bench, centrifuge the 1.5ml centrifuge tube containing the positive plasmid dry powder for 5 minutes, add TE Buffer to the positive plasmid dry powder, and dilute to a concentration of 1.134×10 9 Copy / ul, marked as "positive plasmid 10 9 ″; Copy number calculation formula: Copy number = (6.02×10 14 )a / 660b (a: stock solution concentration, b: plasmid length).

[0040] Dilution of each positive plasmid was performed as follows:

[0041] ① Take 100ul 10 9 Copy / ul of each plasmid into a 1.5ml centrifuge tube, add 900ul TE Buffer at a concentration of 10 8 Copy / ul, labeled as "plasmid 10 8 ″. Vortex for 5 min and centrifuge for 30 s.

[0042] ②Take 100ul 10 8 Copy / ul of each plasmid into a 1.5ml centrifuge tube, add 900ul TE Buffer at a concentration of 10 7 Copy / ul, labeled as "plasmid 10 7 ″. Vortex for 5 min and centrifuge for 30 s.

[0043] ③Take 100ul 10 7 Copy / ul of each plasmid into a 1.5ml centrifuge tube, add 900ul TE Buffer at a concentration of 10 6 Copy / ul, labeled as "plasmid 10 6 ″. Vortex for 5 min and centrifuge for 30 s.

[0044] Dilute to 10 3Then, fluorescent quantitative PCR was performed in sequence according to the gradient until the CT value of each positive plasmid could not be detected, and then the minimum detection limit of each positive plasmid was recorded.

[0045] The sensitivity results are shown in Table 2:

[0046] Table 2

[0047]

[0048]

[0049] Note: In Table 2, NADC30-1 and NADC30-2 are the fragments amplified by two pairs of primers of the NADC30 strain. The same is true for other genotypes. "-1" and "-2" are the fragments amplified by two pairs of primers for one genotype.

[0050] Twelve-plex fluorescence quantitative PCR stability experiment: select 10 5 copies / mL, 10 6 copies / mL, 10 7 The three genotype standards with 100 copies / mL dilutions were tested repeatedly (5 μL of three dilutions of the standard was taken as a template), and 10 replicates were performed for each, and the coefficient of variation was calculated using the coefficient of variation calculation formula. The results showed that the coefficient of variation of the three gradients was less than 2% (as shown in Table 3), indicating that the method has good repeatability.

[0051] Table 3

[0052] 1 <![CDATA[10 7 ]]> 20.55 <![CDATA[10 6 ]]> 23.51 <![CDATA[10 5 ]]> 27.07 2 <![CDATA[10 7 ]]> 20.38 <![CDATA[10 6 ]]> 23.64 <![CDATA[10 5 ]]> 26.88 3 <![CDATA[10 7 ]]> 20.45 <![CDATA[10 6 ]]> 23.55 <![CDATA[10 5 ]]> 26.79 4 <![CDATA[10 7 ]]> 20.72 <![CDATA[10 6 ]]> 23.71 <![CDATA[10 5 ]]> 26.89 5 <![CDATA[10 7 ]]> 20.66 <![CDATA[10 6 ]]> 23.87 <![CDATA[10 5 ]]> 26.74 6 <![CDATA[10 7 ]]> 20.44 <![CDATA[10 6 ]]> 24.06 <![CDATA[10 5 ]]> 27.11 7 <![CDATA[10 7 ]]> 20.93 <![CDATA[10 6 ]]> 23.62 <![CDATA[10 5 ]]> 27.20 8 <![CDATA[10 7 ]]> 21.04 <![CDATA[10 6 ]]> 24.17 <![CDATA[10 5 ]]> 26.96 9 <![CDATA[10 7 ]]> 20.62 <![CDATA[10 6 ]]> 23.67 <![CDATA[10 5 ]]> 26.83 10 <![CDATA[10 7 ]]> 20.36 <![CDATA[10 6 ]]> 23.77 <![CDATA[10 5 ]]> 26.74 average value <![CDATA[10 7 ]]> 20.615 <![CDATA[10 6 ]]> 23.757 <![CDATA[10 5 ]]> 26.921 Standard Deviation <![CDATA[10 7 ]]> 0.2299 <![CDATA[10 6 ]]> 0.2164 <![CDATA[10 5 ]]> 0.1602 CV% <![CDATA[10 7 ]]> 1.11 <![CDATA[10 6 ]]> 0.91 <![CDATA[10 5 ]]> 0.6

[0053] Clinical sample compliance verification:

[0054] Suspicious clinical samples (a total of 200 samples, some of which may be infected with the virus) were tested simultaneously using this twelve-plex fluorescent quantitative PCR primer set and commercially available single-plex detection kits. Two commercially available detection kits, A, B, C, D, E, and F, were used separately to detect six genotypes of blue ear (a total of 12 types).

[0055] After testing, the test results of kit A on the samples were:

[0056] There were 37 positive cases of NADC30; the results of B box were: 39 positive cases of NADC34 in 200 samples; the results of C box were: 22 positive cases of high pathogenic blue ear in 200 samples; the results of D box were: 40 positive cases of classic blue ear American type in 200 samples; the results of E box were: 19 positive cases of blue ear European type in 200 samples; the results of F box were: 15 positive cases of blue ear GM2 in 200 samples. There were 28 negative samples in total.

[0057] Using twelve-plex fluorescence quantitative PCR, after testing the samples that tested positive with box A, 37 cases were still all positive; after testing the samples that tested positive with box B, 39 cases were still all positive; after testing the samples that tested positive with box C, 22 cases were still all positive; after testing the samples that tested positive with box D, 40 cases were still all positive; after testing the samples that tested positive with box E, 19 cases were still all positive; after testing the samples that tested positive with box F, 15 cases were still all positive; the results were completely consistent with the results of boxes A to F.

[0058] The detection results of this patent are consistent with those of commercial detection kits on the market, indicating that the multiple fluorescence quantitative detection method of this patent can be used for the detection of clinical samples with reliable sensitivity and accuracy.

[0059] Twelve-plex fluorescence quantitative PCR specific experiment:

[0060] Six different primer probe MIXs were configured, each containing 10 pairs of primer probes of five genotypes and a plasmid of another genotype that did not match the five genotypes, to conduct specific experiments, and no nonspecific amplification occurred. This shows that the method established in this experiment is highly specific, and no mismatches occurred between the 12 primer pairs and their probes.

[0061] Then prepare 20 samples, 12 plasmid positive (two positive for each genotype) and 8 negative. Experimenter No. 1 numbered 1-20, 1-12 were positive controls (1 and 2 were NADC30 positive, 3 and 4 were NADC34 positive, 5 and 6 were highly pathogenic positive, 7 and 8 were classic American type positive, 9 and 10 were European type positive, 11 and 12 were GM2), and 13-20 were negative controls. 1-20 were shuffled and renumbered as AJ and handed over to experimenter No. 2 for testing to see if there would be false positives and false negatives. The test results are as follows (as shown in Table 4):

[0062] Table 4

[0063]

[0064]

[0065] There were no false positives or false negatives in the test results, indicating that the twelve-plex multiplex PCR has a high specificity.

[0066] Construction of sequencing library:

[0067] After the twelve-plex PCR targeted enrichment, the sequencing library was constructed according to the SQK-NBD114.24 ligation kit (Oxford Nanopore Technologies). The reagents required for each process are as follows:

[0068]

[0069]

[0070] The specific operations are as follows:

[0071] 1. PCR product purification:

[0072] Add a single PCR reaction product to each new 1.5mL centrifuge tube, add 12μL magnetic beads, flick to mix, centrifuge briefly, and incubate at room temperature for 5min. After a brief centrifugation, place on a magnetic rack for adsorption, wait until the liquid is completely clear, and discard the supernatant.

[0073] Add 200 μL of washing solution along the tube wall, wait until the liquid is completely clear, and discard the supernatant. Wash twice in this way, and then add 15 μL of elution solution to rinse the magnetic beads;

[0074] Gently flick the centrifuge tube, place it at room temperature for 2 minutes for instant centrifugation, and then put it back on the magnetic rack. When the solution becomes clear, pipette 15 μL of the clear liquid and transfer it to a new 1.5 mL conical bottom centrifuge tube.

[0075] Take 1 μL of the purified product for Qubit quantification.

[0076] 2. End repair:

[0077] In a 0.2mL PCR tube, add 100ng of the purified PCR product. If the volume is less than 12.5μL, add nuclease-free water to make it 12.5μL. Mix the ingredients in the table below, flick to mix, and centrifuge briefly.

[0078] Reagent name Dosage Purified PCR product 12.5uL End Repair Master Mix 1.75uL End repair enzymes 0.75uL Total volume 15uL

[0079] Incubate in a metal bath according to the conditions in the table below;

[0080] temperature time 20℃ 5min 65℃ 5min

[0081] After the incubation, add 15 μL of magnetic beads to each tube, flick to mix, incubate at room temperature for 5 min, centrifuge briefly, place on a magnetic rack until clear, and discard the supernatant;

[0082] Keep the magnet in the state of absorption, add 200 μL of the prepared washing solution, then discard the supernatant, and wash twice in this way;

[0083] Centrifuge briefly, magnetically aspirate, and remove the remaining washing solution with a pipette;

[0084] Add 10 μL of elution buffer, flick the tube bottom to resuspend, incubate at room temperature for 2 minutes, and centrifuge immediately. Place on a magnetic stand and absorb until clear;

[0085] Transfer 10 μL of supernatant to a 1.5 mL centrifuge tube, which is the unrepaired product;

[0086] 3. Tag connection:

[0087] Remove the barcode (NB01-24), mix, centrifuge, and each sample or quality control requires a separate label number;

[0088] In a 0.2 mL PCR tube, prepare the following reaction;

[0089] Reagent name Dosage End repair products 7.5μl Barcode NB01-24 2.5μl Ligase Master Mix 1 10ul Total volume 20μL

[0090] Mix by flicking gently, centrifuge briefly, and incubate at room temperature for 20 min;

[0091] Then, 2 μL EDTA (ONT ligation sequencing kit) was added to each tube, mixed, and centrifuged briefly;

[0092] Pipette all the ligation products into a 1.5mL centrifuge tube and mix well. Add 0.4 times the total volume of magnetic beads (e.g., add 40μL of magnetic beads to 100μL of mixed product) for purification; flick to mix, centrifuge briefly, and incubate at room temperature for 10 minutes;

[0093] Then place on the magnetic stand for at least 5 minutes until it becomes clear, and discard the supernatant;

[0094] Keep the magnet in the state of absorption, add 700μL of the prepared washing solution for washing, and discard the supernatant. Wash twice in this way;

[0095] Centrifuge briefly, place the centrifuge tube back on the magnetic stand, and remove the remaining washing solution with a pipette;

[0096] Add 35 μL of elution buffer, flick the tube bottom to resuspend, centrifuge briefly, and incubate at 37°C for 10 min;

[0097] Centrifuge briefly and place on a magnetic stand to absorb until clear. Transfer 35 μL of supernatant to a 1.5 mL centrifuge tube, which is the tag-linked product.

[0098] 4. Connector connection:

[0099] In a 1.5 mL centrifuge tube, mix the following reagents in the order shown in the table below. After adding each reagent, pipette and mix 10 to 20 times, mix thoroughly, centrifuge briefly, and incubate at room temperature for 20 minutes.

[0100]

[0101]

[0102] Add 20 μL of magnetic beads, mix well and incubate for 10 min;

[0103] Remove the centrifuge tube, centrifuge it momentarily, place it on a magnetic stand and absorb it until it is clear, and discard the supernatant;

[0104] Add 125 μL SFB, flick to resuspend, and centrifuge briefly. Place on a magnetic stand and absorb until clear, then discard the supernatant. Repeat twice;

[0105] Centrifuge briefly, put the centrifuge tube back on the magnetic rack, remove the residual liquid with a pipette, then add 15 μL EB, flick to mix, centrifuge briefly, and incubate at 37°C for 10 min;

[0106] Centrifuge briefly and place on a magnetic stand until the solution is clear. Transfer 15 μL of supernatant to a 1.5 mL centrifuge tube, which is the prepared nucleic acid library.

[0107] Take 1 μL of the prepared library for Qubit quantification. The ideal total amount of library loaded on the machine is 3.3ng-6.7ng. If the library concentration is too high, it can be diluted with EB.

[0108] 5. Loading the chip:

[0109] The chip was equilibrated at room temperature for about 10 minutes and quality checked (the quality check steps were performed according to the ONT manual).

[0110] Prepare Priming Reagent FB in a 1.5 mL centrifuge tube according to the following table:

[0111] Reagent name Dosage Flow Cell Flush (FCF) 1170μL Flow Cell Tether(FCT) 30μL Auxiliary buffer 5μL Total volume 1205μL

[0112] Prepare the sequencing chip: Open the priming port by rotating 90° clockwise and remove bubbles;

[0113] Pipette 800 μL FB and push it into the pipeline at a constant speed from the priming port hole, and equilibrate at room temperature for 5 minutes;

[0114] Prepare the library for the machine according to the table below. If the prepared nucleic acid library is less than 12μL, add EB to make up 12μL;

[0115]

[0116]

[0117] After the chip is balanced, draw 200 μL of FB and push it into the pipeline from the Priming port hole at a constant speed, so that FB flows out from the SpotONsample port and then falls back, thereby rinsing the area around the SpotON sample port.

[0118] Mix the prepared library several times by pipetting, take 75 μL and add it dropwise into the SpotON sample port. The loading beads can be seen to be evenly dispersed.

[0119] First close the SpotON sample cover, then close the Priming port, and finally remove the liquid from the line from Waste port 1. Place it on the sequencer and set up the experiment.

[0120] 6. Nanopore single-molecule sequencing accuracy verification:

[0121] Prepare 5 samples, numbered 1-5, sample 1 is the amplification product of NADC30 positive sample, sample 2 is the amplification product of NADC34 positive sample, sample 3 is the amplification product of blue ear highly pathogenic positive sample, sample 4 is the amplification product of classic blue ear American type sample, and sample 5 is the amplification product of classic blue ear European type sample. Samples 1-5 were shuffled and randomly renumbered as A, B, C, D, and E. The second experimenter constructed the library and operated on the computer. Data analysis was performed after 1 hour of sequencing. If the number of microbial reads in the sample was not 0, it was judged to be positive for this microorganism. The analysis results are as follows:

[0122] First number Second number Target reads ratio (%) Are there other pathogen reads? 1 B 95.15 none 2 D 94.61 none 3 A 93.97 none 4 C 96.12 none 5 E 95.98 none

[0123] It should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention rather than to limit it. Although the present invention has been described in detail with reference to the preferred embodiments, those skilled in the art should understand that the technical solutions of the present invention may be modified or replaced by equivalents without departing from the spirit and scope of the technical solutions of the present invention, which should all be included in the scope of the claims of the present invention.

Claims

1. A PCR primer set for detecting porcine reproductive and respiratory syndrome virus, characterized in that: The PCR primer set consists of 12 pairs of primers and probes thereof, and the sequences of the PCR primers are shown in SEQ ID NOs: 1-36.

2. A nanopore sequencing method based on single molecule sequencing, characterized in that: The method comprises using the PCR primer set described in claim 1 to detect six types of porcine reproductive and respiratory syndrome virus, namely, PRRSV European strain, C-PRRSV strain among American strains, highly pathogenic HP-PRRSV strain, NADC30 strain, NADC34 strain, and PRRSV GM2 strain.

3. The nanopore sequencing method for single molecule sequencing according to claim 2, characterized in that: The method comprises the following steps: (1) collecting samples and extracting viral nucleic acid; (2) 12-plex fluorescence quantitative PCR amplification; (3) Construction of sequencing library; (4) PRRSV multi-genotype sequencing; (5) Bioinformatics analysis; Wherein, the 12-plex fluorescence quantitative PCR amplification adopts the 12 pairs of primers and probes thereof as described in claim 1 for PCR amplification.

4. The nanopore sequencing method for single molecule sequencing according to claim 3, characterized in that: The amplification program of the 12-plex fluorescent quantitative PCR was pre-denaturation at 95° C. for 3 min, denaturation at 95° C. for 10 s, extension at 65° C. for 3 min, and 40 reaction cycles.

5. The nanopore sequencing method for single molecule sequencing according to claim 3 or 4, characterized in that: The samples include saliva samples, environmental samples, blood samples, and tissue samples.

6. The nanopore sequencing method for single molecule sequencing according to claim 3, characterized in that: The construction of the sequencing library is to construct a nanopore sequencing library according to a ligation kit, including PCR product purification, end repair, label ligation, and adapter ligation.

7. The nanopore sequencing method for single molecule sequencing according to claim 3, characterized in that: The bioinformatics analysis includes database establishment, data capture, host sequence removal, data analysis, statistics on the proportion of detected pathogens, and database comparison.

Citation Information

Patent Citations

  • North american porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof

    CN107974452A

  • Porcine reproductive and respiratory syndrome virus identification and detection kit

    CN114045363A

  • Porcine reproductive and respiratory syndrome virus RT-qPCR (real-time quantitative polymerase chain reaction) detection primer, kit and application thereof

    CN117844988A

  • Super-multiplex PCR (polymerase chain reaction) primer group and super-multiplex PCR and nanopore sequencing method for detecting broad-spectrum pig pathogens

    CN118240972A